CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX), a specialty pharmaceutical company, is focused on the development, licensing and commercialization of pharmaceutical products through the leveraging of their validated drug delivery technology. The company has U.S. and international patents as well as other proprietary rights to technologies that encourage the absorption of drugs. For further information, visit the Company’s web site at www.cpexpharm.com.
- 17 years ago
QualityStocks
CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Gloo Holdings, Inc. (NASDAQ: GLOO) Prices $72.8 Million IPO
Gloo (NASDAQ: GLOO) , a technology platform serving the faith and flourishing ecosystem, priced its…
-
QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Positioned for Growth as War Department Launches Billion-Dollar Push for U.S. Drone Dominance
Safe Pro Group (NASDAQ: SPAI), a mission-driven provider of AI-powered defense and security solutions, is…
-
QualityStocksNewsBreaks – Decent Holding Inc. (NASDAQ: DXST) Closes $8 Million Registered Offering of Class A Shares and Warrants
Decent Holding (NASDAQ: DXST), an established wastewater treatment services provider in China, closed its $8…